OpenAI Seeks Billions While Google Gemini 3.0 Advances Plus Meta Spends

The artificial intelligence sector is currently experiencing a significant shift, moving from foundational infrastructure development towards widespread practical application, a trend noted by investment strategists. Despite this, demand for core AI infrastructure, particularly chips, continues to outpace global supply, a sentiment echoed by Alibaba CEO Eddie Wu, who dismisses fears of an AI bubble and anticipates undersupply for the next three years. Alibaba's cloud computing business, which heavily features AI, grew by 34% to RMB 39.8 billion, and its Qwen app, a direct competitor to ChatGPT, garnered over 10 million downloads in its first week. The company plans to aggressively invest in AI infrastructure, potentially increasing its RMB 380 billion commitment, having already spent RMB 120 billion. However, not all AI-related ventures are seeing immediate success. Peloton, for instance, reported slow initial sales for its new AI-enhanced fitness equipment, including upgraded Bike, Bike+, Tread, and Tread+ models featuring Peloton IQ. In response, Peloton reduced prices by up to $1,500 and increased supply to stimulate holiday demand. Meanwhile, major tech companies are navigating substantial AI investments with varying degrees of investor confidence. Softbank's stock has plunged 40% since October due to concerns over its large AI commitments, which include a $500 billion Stargate project for data centers and a $30 billion investment in OpenAI. To help fund these initiatives, Softbank sold all its Nvidia shares for $5.83 billion. OpenAI itself is not expected to be profitable until 2028 and requires hundreds of billions more in funding, while Alphabet's Gemini 3.0 now directly challenges OpenAI's GPT-5.1. Meta also faces investor scrutiny regarding its substantial AI spending. The company is financing a $27 billion AI data center using off-balance sheet accounting through a joint venture called Hyperion, where Meta holds 20% and Blue Owl Capital owns 80%. Experts caution that increased AI bond issuance by tech giants could lead to lower credit ratings for weaker companies like Meta, potentially raising their borrowing costs by 2030. On a more positive note for investors, Celestica stock on the TSX saw a significant increase, indicating growing interest in Canadian AI stocks. AI is also rapidly transforming drug development, cutting the time to market for new medications from 10-15 years down to 3-6 years, a trend benefiting funds like the BlackRock Health Sciences Term Trust (BMEZ), which invests in companies like Alnylam, a leader in RNA interference using AI. In the crypto space, Bitget introduced seven GetAgent AI traders to mentor users, offering diverse strategies and performance metrics for informed trading decisions. For individual investors, AI tools can enhance research by quickly analyzing SEC filings, though caution is advised to mitigate optimism bias and

Key Takeaways

  • Alibaba's cloud computing business, including AI, grew 34% to RMB 39.8 billion, with its Qwen AI app reaching 10 million downloads in its first week.
  • Alibaba CEO Eddie Wu plans aggressive investments in AI infrastructure, potentially exceeding the RMB 380 billion already committed, due to demand outstripping chip supply.
  • Softbank's stock fell 40% due to concerns over its AI investments, including a $30 billion commitment to OpenAI and a $500 billion Stargate project, funded partly by selling $5.83 billion in Nvidia shares.
  • OpenAI is not projected to be profitable until 2028 and requires substantial additional funding, while Google's Gemini 3.0 now directly competes with OpenAI's GPT-5.1.
  • Meta's $27 billion AI data center is being financed using off-balance sheet accounting through a joint venture, raising investor concerns about its large AI spending and potential credit rating impacts.
  • Peloton experienced slow initial sales for its new AI-enhanced fitness equipment, leading to price reductions of up to $1,500 to boost demand.
  • AI is significantly accelerating drug development, reducing time to market from 10-15 years to 3-6 years, benefiting funds like BlackRock Health Sciences Term Trust (BMEZ).
  • Bitget launched seven GetAgent AI traders to mentor crypto users, offering diverse strategies and performance insights for trading decisions.
  • Investors are shifting focus from core AI infrastructure to companies effectively integrating AI into practical applications, impacting earnings.
  • AI tools can enhance investor research by analyzing SEC filings, but users should apply clear rules to mitigate risks like optimism bias or

    Alibaba Stock Falls Despite Strong AI Cloud Growth

    Alibaba stock dropped over 2% even though its cloud computing business, which includes AI, grew by 34% to RMB 39.8 billion. CEO Eddie Wu stated the company struggles to meet customer demand for AI infrastructure and might increase its RMB 380 billion investment plan. Alibaba has already spent RMB 120 billion on AI and cloud. Its quick commerce business also saw a 60% revenue surge. The company's Qwen app, an AI rival to ChatGPT, reached 10 million downloads in its first week.

    Alibaba CEO Dismisses AI Bubble Fears Plans Big Investments

    Alibaba CEO Eddie Wu believes there is no AI bubble, stating that demand for AI technology is growing faster than the global supply of chips. He announced plans to invest "aggressively" in AI infrastructure, suggesting the previously announced 380 billion yuan investment might be too small. Alibaba's cloud division, which includes its Qwen platform, grew 34% to 39.8 billion yuan. The Qwen app also saw over 10 million downloads in its first week. Wu expects AI resources to remain undersupplied for the next three years.

    Peloton Sees Slow Sales for New AI Fitness Gear

    Peloton is experiencing slow initial sales for its new AI-enhanced fitness equipment, including upgraded Bike, Bike+, Tread, and Tread+ models with Peloton IQ. The company launched these new products in September but has seen modest sales in the first eight weeks. In response, Peloton reduced prices by up to $1,500 and increased its supply to boost holiday demand. Despite strong gross margins, the company's financial health is rated as poor due to high debt and low interest coverage.

    Celestica Stock Soars Canadian AI Investments Rise

    Celestica stock, traded on the TSX, saw a significant increase on Monday. This rise suggests a growing interest in Canadian AI stocks. Investors are looking at companies like Celestica as good opportunities in the expanding artificial intelligence market.

    How AI Can Improve Investing Decisions Safely

    AI tools can help investors analyze SEC filings quickly, but they might also show optimism bias or "hallucinate" information. Investor Brian Feroldi suggests using AI as a research assistant by setting clear rules. These rules include limiting AI to trusted sources, giving step-by-step instructions, and assigning it a specific role. This approach helps investors use AI to strengthen their research process and make better decisions, rather than relying on it to pick stocks.

    Meta's AI Spending Raises Investor Concerns

    Meta's stock is up 5.7% in 2025, but it lags behind the S&P 500's 15.2% rise, causing investor concern about its large AI spending. The company is financing a $27 billion AI data center using off-balance sheet accounting, similar to methods used by Enron. Meta formed a joint venture called Hyperion, owning 20% while Blue Owl Capital owns 80%, to keep the debt off its balance sheet. Experts warn that increased AI bond issuance by tech giants could lower credit ratings for weaker companies like Meta, raising their borrowing costs by 2030.

    BlackRock Fund Benefits From AI Drug Development

    AI is rapidly changing drug development, cutting the time it takes to bring new medications to market from 10-15 years down to 3-6 years. This change means more profits and new drugs for pharmaceutical companies. The BlackRock Health Sciences Term Trust (BMEZ), a closed-end fund, invests in companies benefiting from this AI revolution in pharma. BMEZ currently offers an 8.8% dividend and trades at a 13% discount to its net asset value. Its top holding, Alnylam, is a leader in RNA interference, a cutting-edge medicine that uses AI to fix disease-causing genes.

    Bitget Introduces AI Mentors for Crypto Trading

    Bitget has launched seven new GetAgent AI traders designed to act as mentors for crypto trading. These AI assistants use a professional database of trading factors and refined strategies to provide insights and make sophisticated trading decisions. Each AI trader has a unique strategy, ranging from conservative to high-volatility approaches, and users can copy their trades. Users can also ask the AI about its logic and view performance metrics like ROI curves to find a trader that fits their style.

    Softbank Stock Plunges 40 Percent on AI Investment Fears

    Softbank's stock has fallen 40% since October as investors grow concerned about its large AI investments. CEO Masayoshi Son committed to the $500 billion Stargate project for data centers and increased Softbank's investment in OpenAI to $30 billion, selling all Nvidia shares for $5.83 billion to help fund it. The company faces significant risks, including taking on more debt for these investments. OpenAI is not expected to be profitable until 2028 and needs hundreds of billions more in funding. Additionally, Alphabet's Gemini 3.0 now poses a direct challenge to OpenAI's GPT-5.1.

    AI Investment Shifts Focus to Practical Use

    The artificial intelligence market is moving from building core infrastructure to widely using AI in practical applications. Robert Teeter, Chief Investment Strategist at Silvercrest Asset Management, notes this shift will significantly impact company earnings. Investors are now looking for companies that effectively integrate AI into their products and services to drive innovation and efficiency. While the economy is growing slowly, bonds are becoming an attractive investment option with yields around 4%. Teeter also expects the market to broaden, with healthcare and small-cap stocks showing particular promise.

    Sources

NOTE:

This news brief was generated using AI technology (including, but not limited to, Google Gemini API, Llama, Grok, and Mistral) from aggregated news articles, with minimal to no human editing/review. It is provided for informational purposes only and may contain inaccuracies or biases. This is not financial, investment, or professional advice. If you have any questions or concerns, please verify all information with the linked original articles in the Sources section below.

Alibaba AI Cloud Cloud Computing AI Infrastructure AI Investment Qwen ChatGPT Stock Market AI Bubble AI Demand Chip Supply Peloton AI Fitness Gear Sales Performance Celestica Canadian AI Stocks AI Tools Investing Decisions Meta Data Centers Investor Concerns BlackRock AI Drug Development Bitget AI Mentors Crypto Trading Trading Strategies Softbank OpenAI Nvidia GPT-5.1 Gemini 3.0 Practical AI Applications Innovation Efficiency Healthcare Sector Small-cap Stocks

Comments

Loading...